dysaesthesia


Also found in: Medical, Wikipedia.

dysaesthesia

(ˌdɪsɪsˈθiːzɪə)
n
a disagreeable sensation such as burning or itching arising from impairment of the nervous systema medical condition of which this is a manifestation
Mentioned in ?
References in periodicals archive ?
Cognisant of the medical definitions (11) of paraesthesia (an abnormal sensation such as burning, pricking, tickling or tingling) and dysaesthesia (an abnormal, unpleasant sensation such as burning, pricking, tickling or tingling) and of descriptions in authoritative anaesthetic texts (12) of paraesthesia (an abnormal sensation, whether spontaneous or evoked) and dysaesthesia (an unpleasant abnormal sensation, whether spontaneous or evoked), we did not enquire into the nature of the sensation occurring at the moment of dural penetration and considered the simple question "Did you feel that?
This may be accompanied by hyperalgesia, allodynia, dysaesthesia or paraesthesiae.
Common symptoms of HFSR include dysaesthesia and paraesthesia, erythema, oedema, hyperkeratosis, dry and/or cracked skin, callous-like blisters and desquamation.
The common adverse reactions associated with the use of Thalidomide in combination with other anti-myeloma therapies are: deep vein thrombosis, constipation, peripheral oedema, tremor, dizziness, fatigue, asthenia, somnolence, peripheral neuropathy, neutropenia, lymphopenia, leucopenia, anaemia, thrombocytopenia, paraesthesia and dysaesthesia.
double dagger]) This includes both frank pain and/or unpleasant dysaesthesia.
Those patients who received written information had significantly better recall of dysaesthesia of the tongue and lip compared to those who received an oral warning only.
He suffers with numbness and dysaesthesia - an unpleasant pins-and-needles, crawling or burning sensation when touched - in his wrist, palm and left ring finger.
Somatosensory findings in patients with spinal cord injury and central dysaesthesia pain.
The common adverse reactions associated with the use of Thalidomide in combination with other anti-myeloma therapies are: deep vein thrombosis, constipation, peripheral edema, tremor, dizziness, fatigue, asthenia, somnolence, peripheral neuropathy, neutropenia, lymphopenia, leucopenia, anemia, thrombocytopenia, paraesthesia and dysaesthesia.
Patients describing motor weakness, allodynia, dysaesthesia or worsening paraesthesia were requested to attend the hospital for clinical assessment.